ea0047oc43 | Innovative Theranostics | Theranostics2016
Ebenhan Thomas
, Suthiram Janine
, Erasmus Danka
, Knoesen Otto
, Wagener Judith
, Marjanovic-Painter Biljana
, Zeevaart Jan Rijn
, Marx Sebastian
, Meckel Marian
, Sathekge Mike M.
Background: The current focus of personalized medicine is towards the use of the theranostic approach the development of an interdependent, collaborative targeted therapeutic and a companion diagnostic test. [DOTA0,D-Phe1,Tyr3]-octreotate (DOTA-TATE) and ligands targeting prostate-specific membrane antigen (PSMA) have been introduced recently as 177Lu-labeled theranostics for neuroendocrine tumors and prostate cancer respectiv...